OKC VAMC Y90 DOSES AND ANCILLARY SUPPLIES FOR PTS WITH LIVER CANCER

Notice ID:

36C25922Q0191

Department/Ind. Agency:

VETERANS AFFAIRS, DEPARTMENT OF

Sub-tier:

VETERANS AFFAIRS, DEPARTMENT OF

Sub Command:

NETWORK CONTRACT OFFICE 19 (36C259)

Office:

NETWORK CONTRACT OFFICE 19 (36C259)

All Dates/Times are:

(utc-06:00) mountain standard time, denver, usa

Updated Published Date:

(utc-06:00) mountain standard time, denver, usa

Original Published Date:

0000-00-00 00:00:00

Original Response Date:

mar 25, 2022 03:00 pm mdt

Inactive Policy:

15 days after date offers due

Original Inactive Date:

apr 09, 2022

Initiative:

• None***--***

Product Service Code:

6505 - drugs and biologicals

Original Set Aside:

1. Background The Nuclear Medicine Service is a vital clinical service within the Oklahoma City VAMC to provide care for our veterans. Y-90 spheres micropsheres consist of biocompatible resin microspheres containing the radioactive isotope yttrium-90. This permanent implant is indicated for the treatment of patients with unresectable metastiatic liver tumors from primary colorectal cancer with adjuvant intra-hepatic artery chemotherapy. 2. Project Scope The Oklahoma City VA Medical Center needs to purchase Y-90 Spheres for therapy in selected patients who meet the requirements (non-resectable liver tumors from primary colorectal cancer). This is a patient specific purchase –and a time sensitive purchase (as it is a radioactive material). 3. Specifications The quantities shown in the solicitation schedule are estimates for this facilities requirments. The Oklahoma City VAMC Nuclear Medicine Service is requesting doses and ancillary supplies. Y-90 Sphere micorspheres therapy consists of 1 (or 2) doses to be delivered to the patient via arterial catheter by Interventional Radiology. Dose must be able to be “split” on day of treatment if there is a late, last minute change in treatment plan as specified by the Interventional Radiologist. Each item is ordered on line by Nuclear Medicine approximately one week prior to patient treatment – dates and times of the therapy are spectifc to each individual patient and treating physician. (Nuclear Medicine will place the orders for each dose - which is patient specific)

6162 S WILLOW DR SUITE 300

Greenwood Village , CO 80111

USA

Primary Point of Contacts:

Thaddeus Gray